Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer

被引：0
|
作者：
Hatzipanagiotou, M. E. [1 ]
Pigerl, M. C. [1 ]
Gerken, M. [2 ,3 ]
Raepple, S. [1 ]
Zeltner, V [1 ]
Ugocsai, P. [1 ]
Ortmann, O. [1 ]
Klinkhammer-Schalke, M. [2 ,3 ]
Seitz, S. [1 ]
机构：
[1] Lehrstuhl Univ Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
[2] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr, Regensburg, Germany
[3] Bavarian Hlth & Food Safety Author, Reg Ctr Regensburg, Bavarian Canc Registry, Regensburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1768845
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P49
引用
收藏
页码：739 / 740
页数：2
相关论文
共 50 条
  • [31] Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer
    Villarreal-Garza, Cynthia
    Ferrigno, Ana S.
    Aranda-Gutierrez, Alejandro
    Frankel, Paul H.
    Ruel, Nora H.
    Fonseca, Alan
    Narod, Steven
    Chavarri-Guerra, Yanin
    Sifuentes, Erika
    Magallanes-Hoyos, Maria Cristina
    Herzog, Josef
    Castillo, Danielle
    Alvarez-Gomez, Rosa M.
    Mohar-Betancourt, Alejandro
    Weitzel, Jeffrey N.
    CANCER RESEARCH COMMUNICATIONS, 2021, 1 (03): : 140 - 147
  • [32] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Impact of Adjuvant Radiation Therapy on Breast Cancer-Specific Survival in Patients With Triple-Negative Breast Cancer
    Margenthaler, Julie A.
    Cyr, Amy E.
    Zoberi, Imran
    Gao, Feng
    Taylor, Marie
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 82 - 82
  • [34] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [35] Is there a subset of patients with triple-negative breast cancer (TNBC) in whom adjuvant chemotherapy may be omitted?
    Li, Eric
    Goldbach, Macy
    Ombres, Christina
    Fayanju, Oluwadamilola
    Zhang, Jennifer
    Elmore, Leisha
    Nayak, Anupma
    Tchou, Julia
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 238 - 240
  • [36] The influence of comorbidity on treatment and survival of triple-negative breast cancer
    Parise, Carol A.
    Caggiano, Vincent
    BREAST JOURNAL, 2020, 26 (09): : 1729 - 1735
  • [37] Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
    Lin, Wei-Xun
    Xie, Yan-Na
    Chen, Yao-Kun
    Cai, Jie-Hui
    Zou, Juan
    Zheng, Jie-Hua
    Liu, Yi-Yuan
    Li, Zhi-Yang
    Chen, Ye-Xi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (31) : 11338 - 11348
  • [38] Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
    Wei-Xun Lin
    Yan-Na Xie
    Yao-Kun Chen
    Jie-Hui Cai
    Juan Zou
    Jie-Hua Zheng
    Yi-Yuan Liu
    Zhi-Yang Li
    Ye-Xi Chen
    World Journal of Clinical Cases, 2022, 10 (31) : 11338 - 11348
  • [39] Neo-adjuvant Chemotherapy for triple-negative breast cancer: a place for platinum?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (12) : 1063 - 1063
  • [40] ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer
    Huang, Kai
    Jakub, James
    Gabriel, Emmanuel
    Moreno-Aspitia, Alvaro
    McLaughlin, Sarah
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7143 - 7143
12345